Zimmer Biomet Holdings, Inc. Share Price Swiss Exchange

Equities

ZBH

US98956P1021

Medical Equipment, Supplies & Distribution

Market Closed - Swiss Exchange 12:47:28 24/04/2024 pm IST 5-day change 1st Jan Change
113 CHF +15.31% Intraday chart for Zimmer Biomet Holdings, Inc. -.--% +15.31%

Financials

Sales 2024 * 7.76B 6.95B 648B Sales 2025 * 8.12B 7.27B 678B Capitalization 23.32B 20.89B 1,948B
Net income 2024 * 998M 894M 83.33B Net income 2025 * 1.2B 1.07B 100B EV / Sales 2024 * 3.56 x
Net Debt 2024 * 4.32B 3.87B 361B Net Debt 2025 * 2.99B 2.68B 250B EV / Sales 2025 * 3.24 x
P/E ratio 2024 *
23.3 x
P/E ratio 2025 *
20 x
Employees 18,000
Yield 2024 *
0.85%
Yield 2025 *
0.86%
Free-Float 64.77%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Zimmer Biomet Holdings, Inc.

1 day+15.31%
3 months+15.31%
6 months+15.31%
Current year+15.31%
More quotes
1 week
113.00
Extreme 113
113.00
1 month
113.00
Extreme 113
113.00
Current year
98.00
Extreme 98
113.00
1 year
97.00
Extreme 97
113.00
3 years
97.00
Extreme 97
160.00
5 years
97.00
Extreme 97
160.00
10 years
86.00
Extreme 86
160.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 48 01/18/01
Director of Finance/CFO 55 01/19/01
Chief Tech/Sci/R&D Officer - 07/21/07
Members of the board TitleAgeSince
Director/Board Member 68 01/07/01
Director/Board Member 68 01/09/01
Director/Board Member 51 12/14/12
More insiders
Date Price Change
07/24/07 113 -.--%
06/24/06 113 -.--%
05/24/05 113 -.--%
04/24/04 113 -.--%
03/24/03 113 -.--%

Delayed Quote Swiss Exchange, April 24, 2024 at 12:47 pm IST

More quotes
Zimmer Biomet Holdings, Inc. specializes in designing, manufacturing, and selling orthopedic and dental reconstruction implants, spinal implants, and traumatology products. Net sales break down by family of products as follows: - reconstruction implants (57.5%): knees replacement (58.8% of net sales), hips replacement (41.2%); - surgical products and traumatology equipment (22.1%); - dental, spinal and craniomaxillofacial implants (12.8%); - other (7.6%): primarily orthopedic surgery materials and instruments used during post-operative rehabilitation. At the end of 2021, the group had approximately 30 production sites worldwide. Net sales are distributed geographically as follows: Americas (61.3%), Europe/Middle East/Africa (21.3%) and Asia/Pacific (17.4%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
113.4 USD
Average target price
136.4 USD
Spread / Average Target
+20.30%
Consensus